Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Sherman

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 2, 2007
Prevention of venous thromboembolism, recurrent stroke, and other vascular events after acute ischemic stroke: the role of low-molecular-weight heparin and antiplatelet therapyDavid G Sherman
Current Medical Research and Opinion|October 9, 2002
AncrodDavid G Sherman
Stroke|January 31, 2007
Stroke prevention in atrial fibrillation: pharmacological rate versus rhythm controlDavid G Sherman
Neurology|April 28, 2004
Reconsideration of TIA diagnostic criteriaDavid G Sherman
Cerebrovascular Diseases (Basel, Switzerland)|December 25, 2003
Antithrombotic and hypofibrinogenetic therapy in acute ischemic stroke: what is the next step?David G Sherman
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 2, 2007
Enoxaparin versus unfractionated heparin in the prevention of venous thromboembolism after acute ischemic stroke: rationale, design, and methods of an open-label, randomized, parallel-group multicenter trialDavid G Sherman, Sandor Soltes, Rita Samuel, et al.
The New England Journal of Medicine|November 22, 2002
Transient ischemic attack--proposal for a new definitionGregory W Albers, Louis R Caplan, J Donald Easton, et al.
Journal of the Neurological Sciences|November 11, 2006
Safety and tolerability of arundic acid in acute ischemic strokeL Creed Pettigrew, Scott E Kasner, Gregory W Albers, et al.
Lancet (London, England)|April 24, 2007
The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparisonDavid G Sherman, Gregory W Albers, Christopher Bladin, et al.
Annals of Internal Medicine|May 21, 2003
Lessons from the Stroke Prevention in Atrial Fibrillation trialsRobert G Hart, Jonathan L Halperin, Lesly A Pearce, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 2, 2007
Prevention of venous thromboembolism, recurrent stroke, and other vascular events after acute ischemic stroke: the role of low-molecular-weight heparin and antiplatelet therapyDavid G Sherman
Current Medical Research and Opinion|October 9, 2002
AncrodDavid G Sherman
Stroke|January 31, 2007
Stroke prevention in atrial fibrillation: pharmacological rate versus rhythm controlDavid G Sherman
Neurology|April 28, 2004
Reconsideration of TIA diagnostic criteriaDavid G Sherman
Cerebrovascular Diseases (Basel, Switzerland)|December 25, 2003
Antithrombotic and hypofibrinogenetic therapy in acute ischemic stroke: what is the next step?David G Sherman
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 2, 2007
Enoxaparin versus unfractionated heparin in the prevention of venous thromboembolism after acute ischemic stroke: rationale, design, and methods of an open-label, randomized, parallel-group multicenter trialDavid G Sherman, Sandor Soltes, Rita Samuel, et al.
The New England Journal of Medicine|November 22, 2002
Transient ischemic attack--proposal for a new definitionGregory W Albers, Louis R Caplan, J Donald Easton, et al.
Journal of the Neurological Sciences|November 11, 2006
Safety and tolerability of arundic acid in acute ischemic strokeL Creed Pettigrew, Scott E Kasner, Gregory W Albers, et al.
Lancet (London, England)|April 24, 2007
The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparisonDavid G Sherman, Gregory W Albers, Christopher Bladin, et al.
Annals of Internal Medicine|May 21, 2003
Lessons from the Stroke Prevention in Atrial Fibrillation trialsRobert G Hart, Jonathan L Halperin, Lesly A Pearce, et al.
Pageof 2